Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease

Citation
Jc. Wang et al., Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease, NEUROLOGY, 55(11), 2000, pp. 1644-1649
Citations number
32
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
NEUROLOGY
ISSN journal
00283878 → ACNP
Volume
55
Issue
11
Year of publication
2000
Pages
1644 - 1649
Database
ISI
SICI code
0028-3878(200012)55:11<1644:EOAGAP>2.0.ZU;2-0
Abstract
Objective: To verify the association between APOE gene promoter polymorphis ms and the development of AD and to determine whether the effect of promote r polymorphisms on AD is independent of the APOE epsilon4 allele, Backgroun d: Three polymorphisms in the APOE promoter have been shown to modify APOE expression in vitro. Several studies have suggested that these polymorphism s may also modulate risk for AD, either independently or by modifying the e ffect of the APOE coding polymorphism. Methods: The authors analyzed allele and genotype distributions for APOE and all three known APOE promoter poly morphisms (-491 A/T, -427 T/C, and -219 G/T) in a study group consisting of 237 subjects with AD and 274 age-matched controls, They then used log-line ar and logistic regression analyses to test for possible interactions betwe en APOE genotype and the promoter polymorphisms on risk of AD. Conclusion: A strong association between the APOE epsilon4 allele and AD was detected r egardless of promoter polymorphism status. In addition, the -491 AA genotyp e appears to be an independent genetic risk factor for AD, The -427 T/C pol ymorphism and the -219 T/G polymorphism were not directly associated with A D.